Statement no. 8: On 21 December 2020, the European Medicines Agency (EMA) announced its evaluation of the vaccine from Pfizer and BioNTech – called Comirnaty – as safe for humans and effective in preventing COVID-19
The vaccine was created based on the mRNA technology developed by the German company BioNTech, which it had already began working on in January 2020, immediately after the publication of the genetic sequence of the SARS-CoV-2 virus.